Fig. 6From: The association between inflammation, arterial stiffness, oxidized LDL and cardiovascular disease in Finnish men with metabolic syndrome – a 15-year follow-up study A The 10-year FINRISK-probability for each subject at baseline and observed strokes and myocardial infarction during 10 years. B The 10-year FINRISK-probability for each subject at baseline and observed composite endpoints during the follow-up of 16.4 ± 0.3 years. Red bars indicate the subjects who had either FINRISK endpoint during 10 years (A) or any of the composite endpoints during the whole follow-up period (B). In A, the dotted red line indicates the mean FINRISK at baseline (10.2%)Back to article page